Transition to chronic pain: opportunities for novel therapeutics
暂无分享,去创建一个
A. Basbaum | T. Wager | R. Dworkin | J. Levine | K. Sluka | T. Yaksh | R. Edwards | J. Katz | A. Kavelaars | R. Ji | L. Porter | G. Terman | N. Schechter | Y. De Koninck | Theodore John Price | J. Bresnahan | Jan F. Chambers | R. Edwards | Yves De Koninck
[1] Yu-Qiu Zhang,et al. Pain regulation by non-neuronal cells and inflammation , 2016, Science.
[2] N. Volkow,et al. Re-energizing the Development of Pain Therapeutics in Light of the Opioid Epidemic , 2016, Neuron.
[3] J. Farrar,et al. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations , 2015, Pain.
[4] Irene Tracey,et al. Pain vulnerability: a neurobiological perspective , 2014, Nature Neuroscience.
[5] M. Baliki,et al. Predicting transition to chronic pain. , 2013, Current opinion in neurology.
[6] J. Rubenstein,et al. Forebrain GABAergic Neuron Precursors Integrate into Adult Spinal Cord and Reduce Injury-Induced Neuropathic Pain , 2012, Neuron.